Get quick answers to your questions about the article from our AI researcher chatbot
{'id': 'https://openalex.org/W2413334594', 'doi': None, 'title': 'Pharmacokinetics of risperidone in chronic schizophrenic patients.', 'display_name': 'Pharmacokinetics of risperidone in chronic schizophrenic patients.', 'publication_year': 1994, 'publication_date': '1994-01-01', 'ids': {'openalex': 'https://openalex.org/W2413334594', 'mag': '2413334594', 'pmid': 'https://pubmed.ncbi.nlm.nih.gov/7530379'}, 'language': 'en', 'primary_location': {'is_oa': False, 'landing_page_url': 'https://pubmed.ncbi.nlm.nih.gov/7530379', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S4306525036', 'display_name': 'PubMed', 'issn_l': None, 'issn': None, 'is_oa': False, 'is_in_doaj': False, 'is_core': False, 'host_organization': 'https://openalex.org/I1299303238', 'host_organization_name': 'National Institutes of Health', 'host_organization_lineage': ['https://openalex.org/I1299303238'], 'host_organization_lineage_names': ['National Institutes of Health'], 'type': 'repository'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}, 'type': 'article', 'type_crossref': 'journal-article', 'indexed_in': ['pubmed'], 'open_access': {'is_oa': False, 'oa_status': 'closed', 'oa_url': None, 'any_repository_has_fulltext': False}, 'authorships': [{'author_position': 'first', 'author': {'id': 'https://openalex.org/A5112071047', 'display_name': 'Richard L. Borison', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I25041050', 'display_name': 'Augusta University', 'ror': 'https://ror.org/012mef835', 'country_code': 'US', 'type': 'education', 'lineage': ['https://openalex.org/I25041050']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'R. L. Borison', 'raw_affiliation_strings': ['Department of Psychiatry Medical College of Georgia, Augusta 30912-3800.'], 'affiliations': [{'raw_affiliation_string': 'Department of Psychiatry Medical College of Georgia, Augusta 30912-3800.', 'institution_ids': ['https://openalex.org/I25041050']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5008488411', 'display_name': 'B. Diamond', 'orcid': 'https://orcid.org/0000-0003-4243-4387'}, 'institutions': [{'id': 'https://openalex.org/I25041050', 'display_name': 'Augusta University', 'ror': 'https://ror.org/012mef835', 'country_code': 'US', 'type': 'education', 'lineage': ['https://openalex.org/I25041050']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'B. Diamond', 'raw_affiliation_strings': ['Medical College of Georgia'], 'affiliations': [{'raw_affiliation_string': 'Medical College of Georgia', 'institution_ids': ['https://openalex.org/I25041050']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5064786524', 'display_name': 'Ananda Pathiraja', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I4210148435', 'display_name': 'Center for Health and Learning', 'ror': 'https://ror.org/053m1nc07', 'country_code': 'US', 'type': 'nonprofit', 'lineage': ['https://openalex.org/I4210148435']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Ananda Pathiraja', 'raw_affiliation_strings': ['Psychiatry and Health Behavior'], 'affiliations': [{'raw_affiliation_string': 'Psychiatry and Health Behavior', 'institution_ids': ['https://openalex.org/I4210148435']}]}, {'author_position': 'last', 'author': {'id': 'https://openalex.org/A5078198531', 'display_name': 'R C Meibach', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I25041050', 'display_name': 'Augusta University', 'ror': 'https://ror.org/012mef835', 'country_code': 'US', 'type': 'education', 'lineage': ['https://openalex.org/I25041050']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'R. C. Meibach', 'raw_affiliation_strings': ['Medical College of Georgia'], 'affiliations': [{'raw_affiliation_string': 'Medical College of Georgia', 'institution_ids': ['https://openalex.org/I25041050']}]}], 'institution_assertions': [], 'countries_distinct_count': 1, 'institutions_distinct_count': 2, 'corresponding_author_ids': [], 'corresponding_institution_ids': [], 'apc_list': None, 'apc_paid': None, 'fwci': 1.442, 'has_fulltext': False, 'cited_by_count': 27, 'citation_normalized_percentile': {'value': 0.713464, 'is_in_top_1_percent': False, 'is_in_top_10_percent': False}, 'cited_by_percentile_year': {'min': 87, 'max': 88}, 'biblio': {'volume': '30', 'issue': '2', 'first_page': '193', 'last_page': '7'}, 'is_retracted': False, 'is_paratext': False, 'primary_topic': {'id': 'https://openalex.org/T10854', 'display_name': 'Bipolar Disorder and Treatment', 'score': 0.9756, 'subfield': {'id': 'https://openalex.org/subfields/2738', 'display_name': 'Psychiatry and Mental health'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, 'topics': [{'id': 'https://openalex.org/T10854', 'display_name': 'Bipolar Disorder and Treatment', 'score': 0.9756, 'subfield': {'id': 'https://openalex.org/subfields/2738', 'display_name': 'Psychiatry and Mental health'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, {'id': 'https://openalex.org/T10023', 'display_name': 'Schizophrenia research and treatment', 'score': 0.9586, 'subfield': {'id': 'https://openalex.org/subfields/2738', 'display_name': 'Psychiatry and Mental health'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, {'id': 'https://openalex.org/T12547', 'display_name': 'Pharmaceutical studies and practices', 'score': 0.9453, 'subfield': {'id': 'https://openalex.org/subfields/2735', 'display_name': 'Pediatrics, Perinatology and Child Health'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}], 'keywords': [{'id': 'https://openalex.org/keywords/half-life', 'display_name': 'Half-life', 'score': 0.58753455}, {'id': 'https://openalex.org/keywords/crossover-study', 'display_name': 'Crossover study', 'score': 0.569191}, {'id': 'https://openalex.org/keywords/bioequivalence', 'display_name': 'Bioequivalence', 'score': 0.541456}, {'id': 'https://openalex.org/keywords/active-metabolite', 'display_name': 'Active metabolite', 'score': 0.5167941}, {'id': 'https://openalex.org/keywords/dopamine-antagonist', 'display_name': 'Dopamine antagonist', 'score': 0.47717658}], 'concepts': [{'id': 'https://openalex.org/C2780057945', 'wikidata': 'https://www.wikidata.org/wiki/Q412443', 'display_name': 'Risperidone', 'level': 3, 'score': 0.975441}, {'id': 'https://openalex.org/C112705442', 'wikidata': 'https://www.wikidata.org/wiki/Q323936', 'display_name': 'Pharmacokinetics', 'level': 2, 'score': 0.78101075}, {'id': 'https://openalex.org/C3941253', 'wikidata': 'https://www.wikidata.org/wiki/Q47270', 'display_name': 'Half-life', 'level': 3, 'score': 0.58753455}, {'id': 'https://openalex.org/C87813604', 'wikidata': 'https://www.wikidata.org/wiki/Q1242899', 'display_name': 'Crossover study', 'level': 4, 'score': 0.569191}, {'id': 'https://openalex.org/C98274493', 'wikidata': 'https://www.wikidata.org/wiki/Q128406', 'display_name': 'Pharmacology', 'level': 1, 'score': 0.5678156}, {'id': 'https://openalex.org/C2777288759', 'wikidata': 'https://www.wikidata.org/wiki/Q4164182', 'display_name': 'Dosing', 'level': 2, 'score': 0.555029}, {'id': 'https://openalex.org/C42404028', 'wikidata': 'https://www.wikidata.org/wiki/Q864940', 'display_name': 'Bioequivalence', 'level': 3, 'score': 0.541456}, {'id': 'https://openalex.org/C149151106', 'wikidata': 'https://www.wikidata.org/wiki/Q4677569', 'display_name': 'Active metabolite', 'level': 3, 'score': 0.5167941}, {'id': 'https://openalex.org/C71924100', 'wikidata': 'https://www.wikidata.org/wiki/Q11190', 'display_name': 'Medicine', 'level': 0, 'score': 0.4968789}, {'id': 'https://openalex.org/C2781353949', 'wikidata': 'https://www.wikidata.org/wiki/Q3271533', 'display_name': 'Dopamine antagonist', 'level': 4, 'score': 0.47717658}, {'id': 'https://openalex.org/C3020079912', 'wikidata': 'https://www.wikidata.org/wiki/Q3918988', 'display_name': 'Plasma concentration', 'level': 2, 'score': 0.45120275}, {'id': 'https://openalex.org/C2776412080', 'wikidata': 'https://www.wikidata.org/wiki/Q7431605', 'display_name': 'Schizophrenia (object-oriented programming)', 'level': 2, 'score': 0.3777433}, {'id': 'https://openalex.org/C185592680', 'wikidata': 'https://www.wikidata.org/wiki/Q2329', 'display_name': 'Chemistry', 'level': 0, 'score': 0.34374738}, {'id': 'https://openalex.org/C126322002', 'wikidata': 'https://www.wikidata.org/wiki/Q11180', 'display_name': 'Internal medicine', 'level': 1, 'score': 0.32079598}, {'id': 'https://openalex.org/C118552586', 'wikidata': 'https://www.wikidata.org/wiki/Q7867', 'display_name': 'Psychiatry', 'level': 1, 'score': 0.16020069}, {'id': 'https://openalex.org/C2776885963', 'wikidata': 'https://www.wikidata.org/wiki/Q245204', 'display_name': 'Antagonist', 'level': 3, 'score': 0.14620233}, {'id': 'https://openalex.org/C170493617', 'wikidata': 'https://www.wikidata.org/wiki/Q208467', 'display_name': 'Receptor', 'level': 2, 'score': 0.073248476}, {'id': 'https://openalex.org/C204787440', 'wikidata': 'https://www.wikidata.org/wiki/Q188504', 'display_name': 'Alternative medicine', 'level': 2, 'score': 0.0}, {'id': 'https://openalex.org/C142724271', 'wikidata': 'https://www.wikidata.org/wiki/Q7208', 'display_name': 'Pathology', 'level': 1, 'score': 0.0}, {'id': 'https://openalex.org/C27081682', 'wikidata': 'https://www.wikidata.org/wiki/Q269829', 'display_name': 'Placebo', 'level': 3, 'score': 0.0}], 'mesh': [{'descriptor_ui': 'D014150', 'descriptor_name': 'Antipsychotic Agents', 'qualifier_ui': 'Q000493', 'qualifier_name': 'pharmacokinetics', 'is_major_topic': True}, {'descriptor_ui': 'D007555', 'descriptor_name': 'Isoxazoles', 'qualifier_ui': 'Q000493', 'qualifier_name': 'pharmacokinetics', 'is_major_topic': True}, {'descriptor_ui': 'D010880', 'descriptor_name': 'Piperidines', 'qualifier_ui': 'Q000493', 'qualifier_name': 'pharmacokinetics', 'is_major_topic': True}, {'descriptor_ui': 'D012559', 'descriptor_name': 'Schizophrenia', 'qualifier_ui': 'Q000378', 'qualifier_name': 'metabolism', 'is_major_topic': True}, {'descriptor_ui': 'D000293', 'descriptor_name': 'Adolescent', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D000328', 'descriptor_name': 'Adult', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D014150', 'descriptor_name': 'Antipsychotic Agents', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D014150', 'descriptor_name': 'Antipsychotic Agents', 'qualifier_ui': 'Q000627', 'qualifier_name': 'therapeutic use', 'is_major_topic': False}, {'descriptor_ui': 'D014150', 'descriptor_name': 'Antipsychotic Agents', 'qualifier_ui': 'Q000008', 'qualifier_name': 'administration & dosage', 'is_major_topic': False}, {'descriptor_ui': 'D002908', 'descriptor_name': 'Chronic Disease', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D018592', 'descriptor_name': 'Cross-Over Studies', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D006801', 'descriptor_name': 'Humans', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D007555', 'descriptor_name': 'Isoxazoles', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D007555', 'descriptor_name': 'Isoxazoles', 'qualifier_ui': 'Q000008', 'qualifier_name': 'administration & dosage', 'is_major_topic': False}, {'descriptor_ui': 'D007555', 'descriptor_name': 'Isoxazoles', 'qualifier_ui': 'Q000627', 'qualifier_name': 'therapeutic use', 'is_major_topic': False}, {'descriptor_ui': 'D008297', 'descriptor_name': 'Male', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D008875', 'descriptor_name': 'Middle Aged', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D010880', 'descriptor_name': 'Piperidines', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D010880', 'descriptor_name': 'Piperidines', 'qualifier_ui': 'Q000008', 'qualifier_name': 'administration & dosage', 'is_major_topic': False}, {'descriptor_ui': 'D010880', 'descriptor_name': 'Piperidines', 'qualifier_ui': 'Q000627', 'qualifier_name': 'therapeutic use', 'is_major_topic': False}, {'descriptor_ui': 'D018967', 'descriptor_name': 'Risperidone', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D012559', 'descriptor_name': 'Schizophrenia', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D012559', 'descriptor_name': 'Schizophrenia', 'qualifier_ui': 'Q000188', 'qualifier_name': 'drug therapy', 'is_major_topic': False}, {'descriptor_ui': 'D013810', 'descriptor_name': 'Therapeutic Equivalency', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}], 'locations_count': 1, 'locations': [{'is_oa': False, 'landing_page_url': 'https://pubmed.ncbi.nlm.nih.gov/7530379', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S4306525036', 'display_name': 'PubMed', 'issn_l': None, 'issn': None, 'is_oa': False, 'is_in_doaj': False, 'is_core': False, 'host_organization': 'https://openalex.org/I1299303238', 'host_organization_name': 'National Institutes of Health', 'host_organization_lineage': ['https://openalex.org/I1299303238'], 'host_organization_lineage_names': ['National Institutes of Health'], 'type': 'repository'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}], 'best_oa_location': None, 'sustainable_development_goals': [{'id': 'https://metadata.un.org/sdg/3', 'score': 0.5, 'display_name': 'Good health and well-being'}], 'grants': [], 'datasets': [], 'versions': [], 'referenced_works_count': 0, 'referenced_works': [], 'related_works': ['https://openalex.org/W3150721075', 'https://openalex.org/W2413334594', 'https://openalex.org/W2383111959', 'https://openalex.org/W2335337542', 'https://openalex.org/W2123864944', 'https://openalex.org/W2034956313', 'https://openalex.org/W2033914357', 'https://openalex.org/W2023226683', 'https://openalex.org/W2014724304', 'https://openalex.org/W1674319952'], 'abstract_inverted_index': {'In': [0], 'a': [1, 9, 125, 132], 'randomized,': [2], 'crossover': [3], 'study,': [4], '24': [5], 'schizophrenic': [6], 'patients': [7], 'received': [8], 'single': [10], '4-mg': [11], 'dose': [12], 'of': [13, 21, 37, 52, 61, 127, 134], 'risperidone': [14, 38, 53, 62, 64, 135], 'in': [15], 'caplet': [16], 'or': [17, 144], 'tablet': [18], 'form.': [19], 'Each': [20], 'the': [22, 58, 69, 118], 'two': [23, 50], 'study': [24], 'periods': [25], 'lasted': [26], '5': [27], 'days.': [28], 'Blood': [29], 'samples': [30], 'to': [31, 76, 86, 100], 'determine': [32], '(by': [33], 'radioimmunoassay)': [34], 'plasma': [35, 70, 93], 'levels': [36], 'and': [39, 63, 80, 89, 96, 104, 107, 111, 130], 'its': [40], 'major': [41], 'metabolite,': [42], '9-hydroxy-risperidone': [43], '(9-OH-risperidone),': [44], 'were': [45, 54], 'obtained': [46], 'each': [47], 'day.': [48], 'The': [49], 'formulations': [51], 'bioequivalent.': [55], 'Following': [56], 'are': [57], 'mean': [59], 'pharmacokinetics': [60], '+': [65], '9-OH-risperidone:': [66], 'area': [67], 'under': [68], 'concentration': [71], 'curve': [72], '(AUC)': [73], 'from': [74, 84], '0': [75, 85], '96': [77], 'hours;': [78, 106], '278.0': [79], '716.9': [81], 'ng.hr/mL;': [82, 91], 'AUC': [83], 'infinity,': [87], '291.9': [88], '762.4': [90], 'peak': [92, 101], 'concentration,': [94, 102], '33.0': [95], '44.5': [97], 'ng/mL;': [98], 'time': [99], '1.39': [103], '1.78': [105], 'elimination': [108], 'half-life,': [109, 137], '14.93': [110], '23.04': [112], 'hours.': [113], 'These': [114], 'results': [115], 'demonstrate': [116], 'that': [117, 140], 'active': [119], 'moiety': [120], '(risperidone': [121], 'plus': [122], '9-OH-risperidone)': [123], 'has': [124], 'half-life': [126], '23': [128], 'hours': [129], 'reveal': [131], 'pool': [133], '(terminal': [136], '14.9': [138], 'hours)': [139], 'may': [141], 'allow': [142], 'twice-daily': [143], 'even': [145], 'once-daily': [146], 'dosing.': [147]}, 'cited_by_api_url': 'https://api.openalex.org/works?filter=cites:W2413334594', 'counts_by_year': [{'year': 2022, 'cited_by_count': 1}, {'year': 2020, 'cited_by_count': 1}, {'year': 2012, 'cited_by_count': 2}], 'updated_date': '2024-12-18T15:42:55.507719', 'created_date': '2016-06-24'}